RN7SL210P

Across TCGA pan-cancer cohorts, RN7SL210P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RN7SL210P data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher RN7SL210P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL210P expression acts as an unfavorable survival marker, although some lineages such as LIHC show a favorable association.

LUSC, BRCA, and THYM are the cancer types where RN7SL210P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	DFS	Tertile	II,III,IV	0.152	0.760	<.001	57	view →
BRCA	OS	Tertile	IV	0.106	0.791	<.001	36	view →
THYM	OS	Tertile	All	0.186	0.931	<.001	21	view →
KIRC	DFS	Tertile	IV	0.217	0.603	.013	18	view →
SKCM	OS	Tertile	IV	0.415	0.861	.014	18	view →
THCA	DFS	Tertile	All	0.732	0.921	.021	18	view →
PRAD	OS	Tertile	All	0.924	0.992	.001	12	view →
LIHC	OS	Tertile	All	0.972	0.739	.024	12	view →
COAD	DFS	Tertile	III,IV	0.145	0.711	<.001	9	view →
MESO	OS	Tertile	III,IV	0.275	0.582	.039	9	view →
HNSC	DFS	Tertile	II,III,IV	0.445	0.603	.034	6	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RN7SL210P–LUSC (DFS)

Open the LUSC breakdown →